Peter Embí, M.D., M.S., president and CEO of the Regenstrief Institute, Inc., will leave the institute in December to assume the position of chair of Vanderbilt University Medical Center’s Department of Biomedical Informatics. He also will serve as senior vice president for research and innovation, a newly created position. He will join the Vanderbilt faculty on January 1, 2022.
During Dr. Embí’s five years at Regenstrief, he has grown the institute’s faculty, overseeing a 50 percent increase in funded research and, in collaboration with long-time partners and new collaborators, expanded the institute’s local, national and international impact in health and healthcare. In 2019-2020, Regenstrief celebrated 50 years of groundbreaking research and plans were laid for the future.
In addition to his position at Regenstrief Institute, Dr. Embí is the Leonard Betley Professor of Medicine and serves as the associate dean for informatics and health services research at the IU School of Medicine; associate director of informatics at the Indiana Clinical and Translational Sciences Institute and as vice president for learning health systems at IU Health.
About Regenstrief Institute
Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform practice and improve the lives of patients around the globe.
Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission.
